Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03413605 · ClinicalTrials.gov registry record · NA
U01 CRC Project for Vietnamese Americans
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 801
- Enrollment target
NCT03413605 is a NA study that has completed, run by Temple University. The registered enrollment target is 801 participants.
The verdict
NCT03413605, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 801 participants
- Enrollment target
Study Summary
Colorectal cancer (CRC) is the second most commonly diagnosed cancer and the third highest cause of mortality in Vietnamese and Asian Americans. CRC incidence is rising rapidly in Vietnamese Americans, but they have among the lowest rates of CRC screening (14%) and are more likely to be diagnosed with advanced stage disease, which is highly preventable. Over 85% of Vietnamese Americans in our region (PA, NJ and NYC) are foreign-born with limited English proficiency, have low SES, and live in economically disadvantaged neighborhoods. Many lack knowledge about CRC risks and screening benefits and have limited access to culturally appropriate preventive care. Center for Asian Health, Temple University will be working with Vietnamese CBOs to address their critical health disparities. The investigators will test the hypothesis that the proposed multilevel CRC intervention will yield higher CRC screening rates compared to the control at 12-month follow-up. This project represents the first large-scale community-based randomized controlled trial of a multilevel, culturally-appropriate intervention to increase CRC screening among underserved Vietnamese. If effective, this innovative CRC intervention can be used as a model program that has potential impact, generalizability and sustainability in Asian American and other underserved ethnic communities.
Interventions
- BEHAVIORAL A Multilevel CBPR Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 801 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2021-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03413605
The ClinicalTrials.gov registry entry for NCT03413605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 801 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A Multilevel CBPR Intervention is the first listed.
NCT03413605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03413605 about?
NCT03413605 is a clinical study titled "U01 CRC Project for Vietnamese Americans". Colorectal cancer (CRC) is the second most commonly diagnosed cancer and the third highest cause of mortality in Vietnamese and Asian Americans. CRC incidence is rising rapidly in Vietnamese Americans, but they have among the lowest rates of CRC screening (14%) and are more likely to be diagnosed wi...
What is the current status of trial NCT03413605?
This trial is currently completed. It is a NA study. The enrollment target is 801 participants. The study started on 2016-06-01. Estimated completion is 2021-04-28.
What interventions are being tested in trial NCT03413605?
The interventions under investigation include: A Multilevel CBPR Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03413605?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.